{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:32:39Z","timestamp":1781220759619,"version":"3.54.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The objective of this study was to determine the rates of patient satisfaction, perceived recurrence of flexion deformity, and additional treatment after collagenase clostridium histolyticum treatment for Dupuytren\u2019s contracture at a minimum of 5-year follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective study was performed of 199 digits in 142 patients who underwent collagenase clostridium histolyticum treatments from April of 2010 to December of 2013 with a minimum of 5-year follow-up. Patients were contacted by telephone regarding perceived recurrence, additional treatment, satisfaction, and willingness to undergo this treatment again.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>At an average 7.2-year follow-up, 160 of 199 digits (80 percent) had perceived recurrence, and 105 of 199 digits (53 percent) underwent additional treatment. Average satisfaction was 6.5 on a Likert scale ranging from 1 to 10, and 67 percent would undergo collagenase clostridium histolyticum treatment again. Multivariable logistic regression analysis showed that higher Charlson Comorbidity Index (OR, 0.77; 95 percent CI, 0.63 to 0.93) and isolated metacarpophalangeal joint involvement (OR, 0.53; 95 percent CI, 0.29 to 0.97) were associated with decreased odds of additional treatment, and higher American Society of Anesthesiologists physical status classification (OR, 2.49; 95 percent CI, 1.35 to 4.48) and nonsmoker status (OR, 0.23; 95 percent CI, 0.09 to 0.59) were associated with willingness to undergo the treatment again.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Patients may be counseled that the long-term perceived recurrence rate of Dupuytren\u2019s contractures after collagenase clostridium histolyticum treatment is high, and more than half of patients seek additional treatment. Satisfaction and willingness to undergo collagenase clostridium histolyticum treatment decrease with perceived recurrence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL QUESTION\/LEVEL OF EVIDENCE:<\/jats:title>\n            <jats:p>Therapeutic, III.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000007243","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:02:13Z","timestamp":1603411333000},"page":"1071-1079","source":"Crossref","is-referenced-by-count":20,"title":["Collagenase Treatment of Dupuytren\u2019s Disease with Minimum 5-Year Follow-Up: Recurrence, Reintervention, and Satisfaction"],"prefix":"10.1097","volume":"146","author":[{"given":"Dafang","family":"Zhang","sequence":"first","affiliation":[{"name":"From the Department of Orthopaedic Surgery, Brigham and Women\u2019s Hospital; and Harvard Medical School."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon E.","family":"Earp","sequence":"additional","affiliation":[{"name":"From the Department of Orthopaedic Surgery, Brigham and Women\u2019s Hospital; and Harvard Medical School."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyra A.","family":"Benavent","sequence":"additional","affiliation":[{"name":"From the Department of Orthopaedic Surgery, Brigham and Women\u2019s Hospital; and Harvard Medical School."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Blazar","sequence":"additional","affiliation":[{"name":"From the Department of Orthopaedic Surgery, Brigham and Women\u2019s Hospital; and Harvard Medical School."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"R1-20230801","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jhsa.2010.08.007","article-title":"Injectable collagenase clostridium histolyticum: A new nonsurgical treatment for Dupuytren\u2019s disease.","volume":"35","author":"Gilpin","year":"2010","journal-title":"J Hand Surg Am"},{"key":"R2-20230801","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture.","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"key":"R3-20230801","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/1753193415600670","article-title":"New insights into the immediate outcome of collagenase injections for Dupuytren\u2019s contracture.","volume":"41","author":"Warwick","year":"2016","journal-title":"J Hand Surg Eur Vol"},{"key":"R4-20230801","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1558944716647101","article-title":"Trends in the treatment of Dupuytren disease in the United States between 2007 and 2014","volume":"12","author":"Lipman","year":"2017","journal-title":"Hand (N Y.)"},{"key":"R5-20230801","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jhsa.2016.07.090","article-title":"The impact of collagenase clostridium histolyticum introduction on Dupuytren treatment patterns in the United States.","volume":"41","author":"Zhao","year":"2016","journal-title":"J Hand Surg Am"},{"key":"R6-20230801","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jhsa.2015.04.036","article-title":"Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-year data.","volume":"40","author":"Peimer","year":"2015","journal-title":"J Hand Surg Am"},{"key":"R7-20230801","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/PRS.0000000000001320","article-title":"Collagenase clostridium histolyticum versus limited fasciectomy for Dupuytren\u2019s contracture: Outcomes from a multicenter propensity score matched study.","volume":"136","author":"Zhou","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"R8-20230801","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.jhsa.2011.08.004","article-title":"Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for Dupuytren contracture.","volume":"36","author":"Chen","year":"2011","journal-title":"J Hand Surg Am"},{"key":"R9-20230801","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/1753193415597421","article-title":"A single injection of collagenase clostridium histolyticum for the treatment of moderate Dupuytren\u2019s contracture: A 2\u2009year follow-up of 47 patients.","volume":"41","author":"McFarlane","year":"2016","journal-title":"J Hand Surg Eur Vol"},{"key":"R10-20230801","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhsa.2012.09.028","article-title":"Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.","volume":"38","author":"Peimer","year":"2013","journal-title":"J Hand Surg Am"},{"key":"R11-20230801","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/1753193418790157","article-title":"Five-year results after collagenase treatment of Dupuytren disease.","volume":"43","author":"Werlinrud","year":"2018","journal-title":"J Hand Surg Eur Vol"},{"key":"R12-20230801","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/SAP.0000000000001068","article-title":"Outcome of Dupuytren contractures after collagenase clostridium histolyticum injection: A single-institution experience.","volume":"79","author":"Hwee","year":"2017","journal-title":"Ann Plast Surg"},{"key":"R13-20230801","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/1753193418786947","article-title":"Three-year recurrence of Dupuytren\u2019s contracture after needle fasciotomy and collagenase injection: A two-centre randomized controlled trial.","volume":"43","author":"Scherman","year":"2018","journal-title":"J Hand Surg Eur Vol"},{"key":"R14-20230801","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.jhsa.2015.06.099","article-title":"The efficacy and safety of concurrent collagenase clostridium histolyticum injections for 2 Dupuytren contractures in the same hand: A prospective, multicenter study.","volume":"40","author":"Gaston","year":"2015","journal-title":"J Hand Surg Am"},{"key":"R15-20230801","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/1753193413519926","article-title":"Collagenase clostridium histolyticum in patients with Dupuytren\u2019s contracture: Results from POINT X, an open-label study of clinical and patient-reported outcomes.","volume":"40","author":"Warwick","year":"2015","journal-title":"J Hand Surg Eur Vol"},{"key":"R16-20230801","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jhsa.2012.10.008","article-title":"Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: Short-term results from 2 open-label studies.","volume":"38","author":"Witthaut","year":"2013","journal-title":"J Hand Surg Am"},{"key":"R17-20230801","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jhsa.2016.03.003","article-title":"Patient satisfaction with collagenase.","volume":"41","author":"Bradley","year":"2016","journal-title":"J Hand Surg Am"},{"key":"R18-20230801","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jhsa.2010.01.003","article-title":"Collagenase injection as nonsurgical treatment of Dupuytren\u2019s disease: 8-year follow-up.","volume":"35","author":"Watt","year":"2010","journal-title":"J Hand Surg Am"},{"key":"R19-20230801","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhsa.2013.10.002","article-title":"Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures.","volume":"39","author":"Coleman","year":"2014","journal-title":"J Hand Surg Am"},{"key":"R20-20230801","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.12.035","article-title":"Cigarette smoking, stress-induced analgesia and pain perception in men and women.","volume":"114","author":"Girdler","year":"2005","journal-title":"Pain"},{"key":"R21-20230801","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/psyp.12241","article-title":"Nicotine withdrawal and stress-induced changes in pain sensitivity: A cross-sectional investigation between abstinent smokers and nonsmokers.","volume":"51","author":"Nakajima","year":"2014","journal-title":"Psychophysiology"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000007243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T23:15:37Z","timestamp":1690931737000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000007243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000007243","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,23]]}}}